Back to Search
Start Over
MMADHC Premature Termination Codons in the Pathogenesis of Cobalamin D Disorder: Potential of Translational Readthrough Reconstitution
- Publication Year :
- 2021
-
Abstract
- Mutations in the MMADHC gene cause cobalamin D disorder (cblD), an autosomal recessive inborn disease with defects in intracellular cobalamin (cbl, vitamin B12) metabolism. CblD patients present methylmalonic aciduria (MMA), homocystinuria (HC), or combined MMA/HC, and usually suffer developmental delay and cognitive deficits. The most frequent MMADHC genetic alterations associated with disease generate MMADHC truncated proteins, in many cases due to mutations that create premature termination codons (PTC). In this study, we have performed a comprehensive and global characterization of MMADHC protein variants generated by all annotated MMADHC PTC mutations in cblD patients, and analyzed the potential of inducible translational PTC readthrough to reconstitute MMADHC biosynthesis. MMADHC protein truncation caused by disease-associated PTC differentially affected the alternative usage of translation initiation sites, protein abundance, and subcellular localization of MMADHC. Aminoglycoside compounds induced translational PTC readthrough of MMADHC truncated variants, allowing the biosynthesis of full-length MMADHC in a PTC-specific manner. Our results suggest that translational PTC readthrough-based interventions could complement current therapies for cblD patients carrying specific MMADHC PTC mutations.
Details
- Database :
- OAIster
- Notes :
- Financial support from Ikerbasque, The Basque Foundation for Science (R.P., J.C.A.-L., and J.M.C.); Ministerio de Economia, Industria y Competitividad (Spain) and FEDER (grant DPI2016-79874-R to J.C.A.-L. and J.M.C., grant SAF2016-79847-R to R.P.); Fundacion Mutua Madrilena (Spain) (grant AP169812018 to J.C.A.-L. and J.M.C). J.D.L.H. acknowledges the Biocruces Bizkaia Health Research Institute contract for Intensification of Research Activities. J.D.L.H. is a member of the European Reference Network for Rare Hereditary Metabolic Disorders (MetabERN)-Project ID No 739543. C.E.N-X. is the recipient of a Miguel Servet research contract from Instituto de Salud Carlos III (ISCIII, Spain) (CP20/00008). L.T. is the recipient of a predoctoral fellowship from Asociacion Espanola Contra el Cancer (AECC, Junta Provincial de Bizkaia, Spain). We thank to Javier Diez-Garcia (Microscopy core facility, Biocruces Bizkaia Health Research Institute) and to Gustavo Perez-Nanclares and Ana Belen de la Hoz (Genetics-Genomics core facility, Biocruces Bizkaia Health Research Institute) for their expert assistance with microscopy and DNA sequencing, respectively, English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1256623791
- Document Type :
- Electronic Resource